Menu

Investors

Tear Sheet

Tear Sheet

Corporate Profile

We are a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with chronic kidney disease.

Stock Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Quote

Change
Volume
52 Week High
52 Week Low
Events
Date Details
September 9, 2024 at 10:30 AM EDT
H.C. Wainwright 26th Annual Global Investment Conference
Listen to webcast
September 6, 2024 at 9:30 AM EDT
Wells Fargo 2024 Healthcare Conference
Listen to webcast
August 14, 2024 at 8:30 AM EDT
Canaccord Genuity 44th Annual Growth Conference
Listen to webcast
News Releases

SEC Filings

Filing date Description View

EFFECT
9999999995-24-002822.pdf

Simplified registration form
0001628280-24-039115.pdf

Report of unscheduled material events or corporate event
0001517022-24-000065.pdf

Quarterly report which provides a continuing view of a company's financial position
0001628280-24-035879.pdf

Report of unscheduled material events or corporate event
0001517022-24-000061.pdf
Print Page
Print Page
Email Page
Email Page
Contact IR
Contact IR
Email Alerts
Email Alerts
Tear Sheet
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us